ClinicalTrials.gov
public full text
Public Domain
Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases
The purpose of this study is to determine whether left ventricular function improves more rapidly with deferoxamine (DFO) and deferiprone (L1) combination therapy than with DFO monotherapy in patients with thalassemia and decreased ejection fractions. Secondary aims include evaluating changes in myocardial iron burden using T2\* and estimating the relative incidence and severity of chelator-induced toxicity.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Amlodipine vs Nitrates Study in Patients With Chronic Stable Angina#994578
- Pilot Randomized Trial With Flecainide in ARVC Patients#842635
- Effect of Furosemide Withdraw in Stable Chronic Heart Failure Outpatients#807800
- A Pilot Feasibility Study in Recovered Heart Failure#866882
- Study of Left Ventricular Function of Patients With Type 2 Diabetes Without Cardiovascular Disease#1009953
Record · ID 1095936
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive